0 CHECKOUT

Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015

  • ID: 3275794
  • May 2015
  • Region: Global
  • 62 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Icddr,b
  • Novartis AG
  • MORE

Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015

Summary

Our clinical trial report, “Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015" provides data on the Shigella Infections (Shigellosis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Shigella Infections (Shigellosis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Shigella Infections (Shigellosis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Icddr,b
  • Novartis AG
  • MORE

List of Tables
List of Figures
Introduction
Shigella Infections (Shigellosis)
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by G7 Countries: Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Shigella Infections (Shigellosis)
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Shigella Infections (Shigellosis) Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Novartis AG
Clinical Trial Overview of Novartis AG
Icddr,b
Clinical Trial Overview of Icddr,b
Clinical Trial Overview of Top Institutes / Government
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
University of Maryland
Clinical Trial Overview of University of Maryland
Institut Pasteur
Clinical Trial Overview of Institut Pasteur
PATH
Clinical Trial Overview of PATH
U.S. Army Medical Research and Materiel Command
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command
U.S. Department of Defense
Clinical Trial Overview of U.S. Department of Defense
University of Maryland, Baltimore
Clinical Trial Overview of University of Maryland, Baltimore
University of Oxford
Clinical Trial Overview of University of Oxford
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Region, 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Europe, Top Countries, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, North America, Top Countries, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015-
Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015-
Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015-
Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Phase, 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Withdrawn Clinical Trials, 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Terminated Clinical Trials, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Shigella Infections (Shigellosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Icddr,b, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Pasteur, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by PATH, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Defense, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, Baltimore, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015-

List of Figures
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Region (%), 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015-
Proportion of Shigella Infections (Shigellosis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015-
Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015-
Shigella Infections (Shigellosis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Phase (%), 2015-
Shigella Infections (Shigellosis) Therapeutics, Global, Clinical Trials by Trial Status, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, by End Point Status, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Shigella Infections (Shigellosis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015-
Shigella Infections (Shigellosis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015-
GlobalData Methodology

Note: Product cover images may vary from those shown
3 of 4

GlaxoSmithKline plc
Novartis AG
Icddr,b

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Alere Inc.
  • Quidel Corporation
  • Ghent Univeristy
  • Novartis AG
  • Philips N.V.
  • Cepheid Inc.